PeptideDB

BSH-IN-1 2553217-91-5

BSH-IN-1 2553217-91-5

CAS No.: 2553217-91-5

BSH-IN-1 is a recombinant enteric bacterial bile salt hydrolase (BSHs) potent and covalent inhibitor of B. longum BSH (G
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

BSH-IN-1 is a recombinant enteric bacterial bile salt hydrolase (BSHs) potent and covalent inhibitor of B. longum BSH (Gram-positive (Gram+)) and B. theta BSH (Gram-negative (Gram+) ) with IC50s of 108 and 427 nM respectively.

Physicochemical Properties


Molecular Formula C25H41FO3
Molecular Weight 408.589651823044
Exact Mass 408.303
CAS # 2553217-91-5
Related CAS # Gut restricted-7;2553218-46-3
PubChem CID 145713829
Appearance White to yellow solid powder
LogP 5.5
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 5
Heavy Atom Count 29
Complexity 623
Defined Atom Stereocenter Count 10
SMILES

FCC(CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](C[C@@H]4C[C@@H](CC[C@]4(C)[C@H]3CC[C@@]21C)O)O)=O

InChi Key XDVGNIBMZHDZLL-GDQMVUAZSA-N
InChi Code

InChI=1S/C25H41FO3/c1-15(4-5-18(28)14-26)19-6-7-20-23-21(9-11-25(19,20)3)24(2)10-8-17(27)12-16(24)13-22(23)29/h15-17,19-23,27,29H,4-14H2,1-3H3/t15-,16+,17-,19-,20+,21+,22-,23+,24+,25-/m1/s1
Chemical Name

(5R)-5-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-fluorohexan-2-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Additionally, BSH-IN-1 (Compound 7) inhibits Gram-positive bacteria (Lactobacillus plantarum WCFS1, C. perfringens ATCC 13124, and Bifidobacterium adolescentis L2-32) as well as Gram-negative bacteria (B. theta VPI-5482, Bacteroides fragilis ATCC 25285 and Bacteroides vuLgatus ATCC 8482). In expanding bacterial cultures, BSH-IN-1 (Compound 7) is also a strong BSH inhibitor, with IC50s of 237 nM and, for Gram-positive and Gram-negative bacteria, B. adolescentis and B. theta, respectively, 1070 nM[1].
ln Vivo BSH-IN-1 (Compound 7) can be intestinally confined and suppresses BSH activity in C57BL/6 mice after a single dose of 10 mg/kg by gavage[1].
Animal Protocol Animal/Disease Models: C57BL/6 mice[1]
Doses: 10 mg/kg
Route of Administration: Single gavage
Experimental Results: Inhibited gut bacterial BSH activity and modulated the bile acid pool in vivo while not Dramatically affected the gut bacterial community.
References

[1]. Development of a covalent inhibitor of gut bacterial bile salt hydrolases.Nat Chem Biol. 2020 Mar;16(3):318-326.


Solubility Data


Solubility (In Vitro) DMSO: 25 mg/mL (61.19 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.4474 mL 12.2372 mL 24.4744 mL
5 mM 0.4895 mL 2.4474 mL 4.8949 mL
10 mM 0.2447 mL 1.2237 mL 2.4474 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.